Paper Details

  1. Home
  2. Paper Details

Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.

Author: BejerotS, BengtssonF, BergqvistP B, HumbleM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study found that a fast decrease in whole blood serotonin levels was associated with poor clinical outcome in patients with obsessive-compulsive disorder treated with serotonin reuptake inhibitors.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Obsessive-compulsive disorder responds almost only to potent serotonin reuptake inhibitors. Previous studies have suggested a relation between serotonergic function and clinical outcome in serotonin reuptake inhibitor treatment of obsessive-compulsive disorder. METHODS: In a randomized,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0006-3223(00)00956-2

データ提供：米国国立医学図書館（NLM）

Serotonin Reactivity and Obsessive-Compulsive Disorder Treatment

The world of [obsessive-compulsive disorder (OCD)] is a complex one, with researchers constantly seeking new ways to understand and treat this debilitating condition. This study delves into the role of [serotonin], a key neurotransmitter, in OCD and its response to treatment. The researchers are exploring the relationship between serotonin levels in the blood and clinical response to treatment with serotonin reuptake inhibitors. The study aims to shed light on the underlying mechanisms of treatment response and to identify potential biomarkers that could predict treatment success.

Serotonin Reactivity: A Potential Predictor of Treatment Success

The study's findings suggest that serotonin reactivity in the blood may be a potential predictor of treatment success in OCD. The researchers found that patients who experienced a faster decrease in serotonin levels after treatment with serotonin reuptake inhibitors tended to have a poorer clinical response. This suggests that serotonin reactivity may be a valuable indicator of individual differences in treatment response, highlighting the importance of personalized medicine in addressing complex conditions like OCD. This research is a small but important step towards understanding the intricacies of OCD treatment and finding ways to optimize treatment outcomes.

The Importance of Personalized Treatment

This research underscores the need for a personalized approach to treating OCD. The study's findings suggest that not all patients respond in the same way to treatment with serotonin reuptake inhibitors. This highlights the importance of considering individual factors, such as serotonin reactivity, when making treatment decisions. This research is a reminder that the desert of OCD treatment is filled with unique pathways, and a one-size-fits-all approach is not always the most effective.

Dr. Camel's Conclusion

This study is like finding a hidden oasis of insight in the vast desert of OCD research. The researchers are exploring the nuances of serotonin reactivity and its impact on treatment response. It's a reminder that each person's journey through OCD is unique, and personalized approaches are crucial to finding the right path to recovery. This research is a beacon of hope, offering a potentially new and effective approach to managing OCD, a condition that can be both challenging and debilitating.

Date :
  1. Date Completed 2001-06-28
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

11239907

DOI: Digital Object Identifier

10.1016/s0006-3223(00)00956-2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.